NCT01153269 - Long-term Effectiveness and Safety in Hepatitis-co-infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Human Immunodeficiency Virus-Infection

Interventions

DRUG

Lopinavir/Ritonavir (Kaletra)

3 capsules 2xdaily or 2 tablets 2xdaily Kaletra

Trial Locations (8)

Site Reference ID/Investigator# 27575, Berlin

Site Reference ID/Investigator# 27592, Berlin

Site Reference ID/Investigator# 27607, Hamburg

Site Reference ID/Investigator# 27588, Dortmund

Site Reference ID/Investigator# 5355, Krefeld

Site Reference ID/Investigator# 27604, Münster

Site Reference ID/Investigator# 27583, Frankfurt

Site Reference ID/Investigator# 27587, Frankfurt